DiscoverThe SparkTackling Emerging Challenges in Tech-enabled Trials with Beth J Hoffman, PhD, CEO of Origami Therapeutics
Tackling Emerging Challenges in Tech-enabled Trials with Beth J Hoffman, PhD, CEO of Origami Therapeutics

Tackling Emerging Challenges in Tech-enabled Trials with Beth J Hoffman, PhD, CEO of Origami Therapeutics

Update: 2022-12-15
Share

Description

Clinical trials are evolving to meet the needs of patients and researchers alike. However, is the industry prepared to tackle emerging challenges in tech-enabled trials? 

In today's episode, our guest, Beth Hoffman, CEO of Origami Therapeutics, discusses these issues and gives insights on how they can be addressed. 

Listen to our latest podcast now for more info!

Are you a sponsor looking for technology solutions to democratize your trials? Visit our website at https://www.castoredc.com/ for more information

Comments 
00:00
00:00
x

0.5x

0.8x

1.0x

1.25x

1.5x

2.0x

3.0x

Sleep Timer

Off

End of Episode

5 Minutes

10 Minutes

15 Minutes

30 Minutes

45 Minutes

60 Minutes

120 Minutes

Tackling Emerging Challenges in Tech-enabled Trials with Beth J Hoffman, PhD, CEO of Origami Therapeutics

Tackling Emerging Challenges in Tech-enabled Trials with Beth J Hoffman, PhD, CEO of Origami Therapeutics

Castor